Skip to content

Author

Meng-Xin Zhao

We have 3 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

SLC2A1 promotes chemo-immunotherapy resistance in lung adenocarcinoma by modulating the AKT signaling pathway

Chemo-immunotherapy has become a standard treatment for lung adenocarcinoma (LUAD), yet the development of dual resistance to platinum-based chemotherapy and PD-1/PD-L1 blockade severely limits durable clinical benefit. This study aimed to identify a unified molecular regulator that concurrently drives chemoresistance...

Jing-Sheng Ruan, Meng-Xin Zhao, Ying-Fu-Gao Yuan et al. · 0 citations
Open access Jul 2026

Genetic landscape features associated with PD-L1 expression status in advanced lung adenocarcinoma: a targeted sequencing analysis

This study delineates distinct genomic landscapes associated with PD-L1 expression, suggesting PD-L1-positive status is linked to an immune-active, kinase-signaling-driven phenotype with mutually exclusive drivers, and PD-L1-negative status correlates with a more immunosuppressive, co-mutation-prone, metabolism-oriente...

Mu-Kun Huang, Zhongqiang Yao, Hua Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.